Racidin Tablet 150mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Prescription medication
IntroBioPharma Co., Ltd.
MFDS item code 201400868 · Approved 2014.02.26
This product's status changed to Expired on 2024.02.26. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers), improvement of gastric mucosal lesions and bleeding, and prevention of Mendelson syndrome
This medication is used for the treatment of gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used as a preoperative medication to prevent Mendelson's syndrome and helps in the treatment of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It is effective in improving gastric mucosal lesions during acute exacerbations of acute and chronic gastritis, and upper gastrointestinal bleeding (such as peptic ulcer, acute stress ulcer, etc.). This medication promotes the recovery of gastric mucosal damage such as erosion, bleeding, erythema, and edema, thereby improving gastric health.
Adults Administer 150mg of ranitidine orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150mg orally twice daily or 300mg once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 300mg twice daily, in the morning and at bedtime. The dosage is the same when this medicine is used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term nonsteroidal anti-inflammatory drug therapy. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150mg twice daily for 8 weeks or 300mg once daily at bedtime. The dose may be increased to 300mg 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150mg 3 times daily and increase as necessary. In cases of severe disease, up to 6g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection. Once oral administration is possible, switch to oral administration and give 150mg twice daily. 5) Premedication (prevention of Mendelson syndrome) Administer 150mg 2 hours before induction of anesthesia. It is also preferable to administer 150mg on the night before surgery. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50ml/min or less, administer 150mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the serum concentration of the medicine; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Ages 8-18: 150mg (2mg per kg body weight) per dose, up to twice daily
This medication should not be used in patients with hypersensitivity to any of its components. Additionally, due to the presence of lactose hydrate, patients with galactose intolerance, lactase deficiency, and glucose-galactose malabsorption should not take this medication. For patients with impaired renal function, the dosage should be adjusted or the dosing interval extended to avoid increased blood concentration. Patients with liver function problems or a history of drug hypersensitivity, as well as elderly patients, should take it with caution. In cases of concurrent use of NSAIDs, elderly patients or those with a history of peptic ulcers should have their condition regularly monitored. Patients with a history of acute porphyria should avoid this medication as it may trigger seizures. This medication may rarely cause severe allergic reactions such as anaphylactic shock, urticaria, angioedema, rash, fever, bronchospasm, and hypotension; if any abnormal symptoms appear, immediately discontinue use and consult a healthcare professional. Blood-related adverse reactions can include neutropenia, leukopenia, and thrombocytopenia, so it is important to undergo blood tests if symptoms like fatigue, bleeding, or fever occur. Transient liver dysfunction may occur; discontinue use immediately if symptoms of jaundice or hepatitis appear. Caution is also needed as changes in heart rate or vascular issues have been reported rarely. Gastrointestinal symptoms can include constipation, nausea, vomiting, abdominal pain, and diarrhea. Neurological symptoms such as dizziness, drowsiness, headache, insomnia, confusion, and hallucinations may occur and require caution, especially in patients with impaired renal function. Endocrine disorders such as gynecomastia, erectile dysfunction, and decreased libido have also been reported. Musculoskeletal issues can include arthralgia, myalgia, and rarely rhabdomyolysis; any abnormal symptoms should be discussed with a healthcare provider immediately. Skin rashes or alopecia may rarely occur. If this medication does not provide therapeutic effects, it is advisable to switch to other treatment methods, and regular monitoring of blood, liver, and kidney function should be conducted. Elderly patients, those with chronic lung diseases, diabetes, and immunocompromised individuals should be cautious as the risk of pneumonia may increase. This medication can interact with other drugs, so especially when taking anticoagulants like warfarin, frequent monitoring of blood coagulation status is necessary. When taken with sucralfate, absorption may be reduced, so a spacing of more than 2 hours between doses is recommended. Women who are pregnant or may become pregnant should only use this medication if its benefits are deemed to outweigh its risks. Nursing women should also use it only when necessary, as this medication may be excreted in breast milk. Safety in pediatric patients has not been fully established, so caution is needed for use. This medication can cause false positives in urine protein tests, so care should be taken with testing methods. In case of overdose, appropriate treatment such as vomiting and gastric lavage should be implemented, and blood dialysis may be considered if necessary. Keep this medication out of reach of children, and do not transfer it to another container for safety. This medication may mask symptoms of gastric cancer; therefore, patients over middle age who have recently developed symptoms of gastric ulcer or dyspepsia should verify the presence of malignancy before use. For long-term use, it is advisable to have an eye examination for ocular health.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is best to store the medication at room temperature between 1 to 30 degrees Celsius. This will help maintain its effectiveness and prevent degradation.
White circular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Prescription medication
IntroBioPharma Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.